Fetal exposure to teratogens: Evidence of genes involved in autism

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 5, 2011, Pages 1254-1265

  Dufour Rainfray, Diane ^a,b,c   Vourc'h, Patrick ^a,b,c   Tourlet, Sébastien ^a   Guilloteau, Denis ^a,b,c   Chalon, Sylvie ^a,b,c   Andres, Christian R ^a,b,c  

^a UNIVERSITÉ DE TOURS   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c Imagerie fonctionnelle ^*  (France)

Author keywords

Alcohol; Autistic spectrum disorder; Epigenetics; Ethanol; Misoprostol; Thalidomide; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; MISOPROSTOL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THALIDOMIDE; VALPROIC ACID;

ALCOHOL ABUSE; ANGIOGENESIS; APOPTOSIS; ASPERGER SYNDROME; AUTISM; CELL PROLIFERATION; CLINICAL FEATURE; COMPULSION; CONGENITAL MALFORMATION; COPY NUMBER VARIATION; DNA METHYLATION; DRUG STRUCTURE; EMBRYOPATHY; FETAL ALCOHOL SYNDROME; GENE; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HISTONE ACETYLATION; HUMAN; HYPOXIA; LANGUAGE DISABILITY; MENTAL DEFICIENCY; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SOCIAL BEHAVIOR; STEREOTYPY; STOMACH ULCER; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; TERATOGENESIS; TERATOGENICITY;

ANIMALS; APOPTOSIS; AUTISTIC DISORDER; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; DISEASE MODELS, ANIMAL; FEMALE; FETUS; HUMANS; MALE; NEURONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SYNAPTIC TRANSMISSION; TERATOGENS;

EID: 79952536293     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2010.12.013     Document Type: Review

References (195)

1. Anderson G.M., Horne W.C., Chatterjee D., Cohen D.J. The hyperserotonemia of autism. Ann. N. Y. Acad. Sci. 1990, 600:331-340.
2. Andres C. Molecular genetics and animal models in autistic disorder. Brain Res. Bull. 2002, 57:109-119.
3. Anthony B., Zhou F.C., Ogawa T., Goodlett C.R., Ruiz J. Alcohol exposure alters cell cycle and apoptotic events during early neurulation. Alcohol Alcohol. 2008, 43:261-273.
4. A.P.A., 1994. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV, Fourth ed. American Psychiatric Association, Washington DC.
5. Ardinger H.H., Atkin J.F., Blackston R.D., Elsas L.J., Clarren S.K., Livingstone S., Flannery D.B., Pellock J.M., Harrod M.J., Lammer E.J., et al. Verification of the fetal valproate syndrome phenotype. Am. J. Med. Genet. 1988, 29:171-185.
6. Arndt T.L., Stodgell C.J., Rodier P.M. The teratology of autism. Int. J. Dev. Neurosci. 2005, 23:189-199.
7. Aronson M., Hagberg B., Gillberg C. Attention deficits and autism spectrum problems in children exposed to alcohol during gestation: a follow-up study. Dev. Med. Child Neurol. 1997, 39:583-587.
8. Bandim J.M., Ventura L.O., Miller M.T., Almeida H.C., Costa A.E. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq. Neuropsiquiatr. 2003, 61:181-185.
9. Bauman M., Kemper T.L. Histoanatomic observations of the brain in early infantile autism. Neurology 1985, 35:866-874.
10. Bauman M.L., Kemper T.L. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 2005, 23:183-187.
11. Belzung C., Leman S., Vourc'h P., Andres C. Rodent models for autism: a critical review. Drug Discov. Today: Dis. Models 2005, 2:93-101.
12. Berkel S., Marshall C.R., Weiss B., Howe J., Roeth R., Moog U., Endris V., Roberts W., Szatmari P., Pinto D., et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat. Genet. 2010, 42:489-491.
13. Biscetti F., Straface G., Pitocco D., Zaccardi F., Ghirlanda G., Flex A. Peroxisome proliferator-activated receptors and angiogenesis. Nutr. Metab. Cardiovasc. Dis. 2009, 19:751-759.
14. Bittigau P., Ikonomidou C. Glutamate in neurologic diseases. J. Child Neurol. 1997, 12:471-485.
15. Boddaert N., Zilbovicius M. Functional neuroimaging and childhood autism. Pediatr. Radiol. 2002, 32:1-7.
16. Bosetti F., Bell J.M., Manickam P. Microarray analysis of rat brain gene expression after chronic administration of sodium valproate. Brain Res. Bull. 2005, 65:331-338.
17. Bosley T.M., Salih M.A., Alorainy I.A., Oystreck D.T., Nester M., Abu-Amero K.K., Tischfield M.A., Engle E.C. Clinical characterization of the HOXA1 syndrome BSAS variant. Neurology 2007, 69:1245-1253.
18. Breyer R.M. Prostaglandin EP1 receptor subtype selectivity takes shape. Mol. Pharmacol. 2001, 59:1357-1359.
19. Bromley R.L., Mawer G., Clayton-Smith J., Baker G.A. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008, 71:1923-1924.
20. Buxhoeveden D.P., Semendeferi K., Buckwalter J., Schenker N., Switzer R., Courchesne E. Reduced minicolumns in the frontal cortex of patients with autism. Neuropathol. Appl. Neurobiol. 2006, 32:483-491.
21. Carper R.A., Courchesne E. Localized enlargement of the frontal cortex in early autism. Biol. Psychiatr. 2005, 57:126-133.
22. Carper R.A., Moses P., Tigue Z.D., Courchesne E. Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage 2002, 16:1038-1051.
23. Casanova M.F., Buxhoeveden D.P., Switala A.E., Roy E. Minicolumnar pathology in autism. Neurology 2002, 58:428-432.
24. Casanova M.F., Van Kooten I.A., Switala A.E., Van Engeland H., Heinsen H., Steinbusch H.W., Hof P.R., Trippe J., Stone J., Schmitz C. Minicolumnar abnormalities in autism. Acta Neuropathol. 2006, 112:287-303.
25. Chakrabarti S., Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001, 285:3093-3099.
26. Chandana S.R., Behen M.E., Juhász C., Muzik O., Rothermel R.D., Mangner T.J., Chakraborty P.K., Chugani H.T., Chugani D.C. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 2005, 23:171-182.
27. Chen B., Wang J.F., Hill B.C., Young L.T. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Mol. Brain Res. 1999, 70:45-53.
28. Chen C.P., Kuhn P., Advis J.P., Sarkar D.K. Chronic ethanol consumption impairs the circadian rhythm of pro-opiomelanocortin and period genes mRNA expression in the hypothalamus of the male rat. J. Neurochem. 2004, 88:1547-1554.
29. Chen C.P., Kuhn P., Advis J.P., Sarkar D.K. Prenatal ethanol exposure alters the expression of period genes governing the circadian function of beta-endorphin neurons in the hypothalamus. J. Neurochem. 2006, 97:1026-1033.
30. Christianson A.L., Chesler N., Kromberg J.G. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 1994, 36:361-369.
31. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45:287-295.
32. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., Da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann. Neurol. 1997, 42:666-669.
33. Clayton-Smith J., Donnai D. Fetal valproate syndrome. J. Med. Genet. 1995, 32:724-727.
34. Coelho K.E., Sarmento M.F., Veiga C.M., Speck-Martins C.E., Safatle H.P., Castro C.V., Niikawa N. Misoprostol embryotoxicity: clinical evaluation of fifteen patients with arthrogryposis. Am. J. Med. Genet. 2000, 95:297-301.
35. D'Amato R.J., Loughnan M.S., Flynn E., Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4082-4085.
36. De Sarno P., Li X., Jope R.S. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 2002, 43:1158-1164.
37. Dean J.C., Hailey H., Moore S.J., Lloyd D.J., Turnpenny P.D., Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet. 2002, 39:251-259.
38. Detich N., Bovenzi V., Szyf M. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 2003, 278:27586-27592.
39. DiLiberti J.H., Farndon P.A., Dennis N.R., Curry C.J. The fetal valproate syndrome. Am. J. Med. Genet. 1984, 19:473-481.
40. Dong E., Guidotti A., Grayson D.R., Costa E. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4676-4681.
41. Dufour-Rainfray D., Vourc'h P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci. Lett. 2010, 470:55-59.
42. Durand C.M., Betancur C., Boeckers T.M., Bockmann J., Chaste P., Fauchereau F., Nygren G., Rastam M., Gillberg I.C., Anckarsater H., et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 2007, 39:25-27.
43. Edwards H.G., Dow-Edwards D.L. Craniofacial alterations in adult rats prenatally exposed to ethanol. Teratology 1991, 44:373-378.
44. Eliasen M., Tolstrup J.S., Nybo Andersen A.M., Grønbæk M., Olsen J., Strandberg-Larsen K. Prenatal alcohol exposure and autistic spectrum disorders--a population-based prospective study of 80 552 children and their mothers. Int. J. Epidemiol. 2010, 39:1074-1081.
45. Ema M., Ise R., Kato H., Oneda S., Hirose A., Hirata-Koizumi M., Singh A.V., Knudsen T.B., Ihara T. Fetal malformations and early embryonic gene expression response in cynomolgus monkeys maternally exposed to thalidomide. Reprod. Toxicol. 2010, 29:49-56.
46. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., Realmuto G.R. Glutamic acid decarboxylase 65 and 67kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatr. 2002, 52:805-810.
47. Folstein S.E., Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat. Rev. Genet. 2001, 2:943-955.
48. Frey B.N., Andreazza A.C., Ceresér K.M., Martins M.R., Valvassori S.S., Réus G.Z., Quevedo J., Kapczinski F. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci. 2006, 79:281-286.
49. Fukuchi M., Nii T., Ishimaru N., Minamino A., Hara D., Takasaki I., Tabuchi A., Tsuda M. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions. Neurosci. Res. 2009, 65:35-43.
50. Ge Y., Belcher S.M., Light K.E. Alterations of cerebellar mRNA specific for BDNF, p75NTR, and TrkB receptor isoforms occur within hours of ethanol administration to 4-day-old rat pups. Dev. Brain Res. 2004, 151:99-109.
51. Geschwind D.H. Advances in autism. Annu. Rev. Med. 2009, 60:367-380.
52. Gillberg C., Steffenburg S. Autistic behaviour in Moebius syndrome. Acta Paediatr. Scand. 1989, 78:314-316.
53. Gillberg C., Steffenburg S., Schaumann H. Is autism more common now than ten years ago?. Br. J. Psychiatr. 1991, 158:403-409.
54. Gillberg C., Winnergård I. Childhood psychosis in a case of Moebius syndrome. Neuropediatrics 1984, 15:147-149.
55. Glessner J.T., Wang K., Cai G., Korvatska O., Kim C.E., Wood S., Zhang H., Estes A., Brune C.W., Bradfield J.P., et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009, 459:569-573.
56. Goodlett C.R., Horn K.H., Zhou F.C. Alcohol teratogenesis: mechanisms of damage and strategies for intervention. Exp. Biol. Med. 2005, 230:394-406.
57. Gulya K., Grant K.A., Valverius P., Hoffman P.L., Tabakoff B. Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 1991, 547:129-134.
58. Gurvich N., Berman M.G., Wittner B.S., Gentleman R.C., Klein P.S., Green J.B. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J. 2005, 19:1166-1168.
59. Gutala R., Wang J., Kadapakkam S., Hwang Y., Ticku M., Li M.D. Microarray analysis of ethanol-treated cortical neurons reveals disruption of genes related to the ubiquitin-proteasome pathway and protein synthesis. Alcohol: Clin. Exp. Res. 2004, 28:1779-1788.
60. Haigh J.J., Morelli P.I., Gerhardt H., Haigh K., Tsien J., Damert A., Miquerol L., Muhlner U., Klein R., Ferrara N., et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev. Biol. 2003, 262:225-241.
61. Hallene K.L., Oby E., Lee B.J., Santaguida S., Bassanini S., Cipolla M., Marchi N., Hossain M., Battaglia G., Janigro D. Prenatal exposure to thalidomide, altered vasculogenesis, and CNS malformations. Neuroscience 2006, 142:267-283.
62. Hard M.L., Abdolell M., Robinson B.H., Koren G. Gene-expression analysis after alcohol exposure in the developing mouse. J. Lab. Clin. Med. 2005, 145:47-54.
63. Harris S.R., MacKay L.L., Osborn J.A. Autistic behaviors in offspring of mothers abusing alcohol and other drugs: a series of case reports. Alcohol: Clin. Exp. Res. 1995, 19:660-665.
64. Heaton M.B., Paiva M., Mayer J., Miller R. Ethanol-mediated generation of reactive oxygen species in developing rat cerebellum. Neurosci. Lett. 2002, 334:83-86.
65. Holliday R. The possibility of epigenetic transmission of defects induced by teratogens. Mutat. Res. 1998, 422:203-205.
66. Holmes L.B. Teratogen-induced limb defects. Am. J. Med. Genet. 2002, 112:297-303.
67. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:16659-16664.
68. Huang P.H., McBride W.G. Interaction of [glutarimide-2-14C]-thalidomide with rat embryonic DNA in vivo. Teratog. Carcinog. Mutagen. 1997, 17:1-5.
69. Hutcheson H.B., Olson L.M., Bradford Y., Folstein S.E., Santangelo S.L., Sutcliffe J.S., Haines J.L. Examination of NRCAM, LRRN3, KIAA0716, and LAMB1 as autism candidate genes. BMC Med. Genet. 2004, 5:12.
70. Ingram J.L., Peckham S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol. Teratol. 2000, 22:319-324.
71. Ito T., Ando H., Suzuki T., Ogura T., Hotta K., Imamura Y., Yamaguchi Y., Handa H. Identification of a primary target of thalidomide teratogenicity. Science 2010, 327:1345-1350.
72. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
73. Johansson M., Wentz E., Fernell E., Strömland K., Miller M.T., Gillberg C. Autistic spectrum disorders in Möbius sequence: a comprehensive study of 25 individuals. Dev. Med. Child Neurol. 2001, 43:338-345.
74. Jones K.L., Smith D.W. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973, 302:999-1001.
75. Kanner L. Autistic disturbances of affective contact. Nerv. Child 1943, 2:217-250.
76. Katoh H., Negishi M., Ichikawa A. Prostaglandin E receptor EP3 subtype induces neurite retraction via small GTPase Rho. J. Biol. Chem. 1996, 271:29780-29784.
77. Kelleher R.J., Bear M.F. The autistic neuron: troubled translation?. Cell 2008, 135:401-406.
78. Kelly S.J., Day N., Streissguth A.P. Effects of prenatal alcohol exposure on social behavior in humans and other species. Neurotoxicol. Teratol. 2000, 22:143-149.
79. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., Lally E., Weiss L.A., Najm J., Kutsche K., et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:199-207.
80. Kim J.S., Shukla S.D. Acute in vivo effect of ethanol binge drinking on histone H3 modifications in rat tissues. Alcohol Alcohol 2006, 41:126-132.
81. Kini U., Adab N., Vinten J., Fryer A., Clayton-Smith J. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch. Dis. Child. Fetal Neonatal Ed. 2006, 91:F90-F95.
82. Kolozsi E., Mackenzie R.N., Roullet F.I., deCatanzaro D., Foster J.A. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience 2009, 163:1201-1210.
83. Kumari M., Anji A. An old story with a new twist: do NMDAR1 mRNA binding proteins regulate expression of the NMDAR1 receptor in the presence of alcohol?. Ann. N. Y. Acad. Sci. 2005, 1053:311-318.
84. Kuwagata M., Ogawa T., Shioda S., Nagata T. Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study. Int. J. Dev. Neurosci. 2009, 27:399-405.
85. Kwon C.H., Luikart B.W., Powell C.M., Zhou J., Matheny S.A., Zhang W., Li Y., Baker S.J., Parada L.F. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
86. Laegreid L., Kyllerman M., Hedner T., Hagberg B., Viggedahl G. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neuropediatrics 1993, 24:88-92.
87. Laeng P., Pitts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H., Thyagarajan R., Mallon B.S., Altar C.A. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J. Neurochem. 2004, 91:238-251.
88. Lam K.S., Aman M.G., Arnold L.E. Neurochemical correlates of autistic disorder: a review of the literature. Res. Dev. Disabil. 2006, 27:254-289.
89. Lamy S., Thibaut F. Psychoactive substance use during pregnancy: a review. Encephale 2010, 36:33-38.
90. Landgren M., Svensson L., Strömland K., Andersson Grönlund M. Prenatal alcohol exposure and neurodevelopmental disorders in children adopted from Eastern Europe. Pediatrics 2010, 125:e1178-e1185.
91. Landrigan P.J. What causes autism? Exploring the environmental contribution. Curr. Opin. Pediatr. 2010, 22:219-225.
92. Laumonnier F., Bonnet-Brilhault F., Gomot M., Blanc R., David A., Moizard M.P., Raynaud M., Ronce N., Lemonnier E., Calvas P., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
93. Lawrence R.C., Bonner H.C., Newsom R.J., Kelly S.J. Effects of alcohol exposure during development on play behaviour and c-Fos expression in response to play behaviour. Behav. Brain Res. 2008, 188:209-218.
94. Lee R.D., An S.M., Kim S.S., Rhee G.S., Kwack S.J., Seok J.H., Chae S.Y., Park C.H., Choi Y.W., Kim H.S., et al. Neurotoxic effects of alcohol and acetaldehyde during embryonic development. J. Toxicol. Environ. Health A 2005, 68:2147-2162.
95. Lenz W., Knapp K. Thalidomide embryopathy. Arch. Environ. Health 1962, 5:100-105.
96. Levitt P. Neuroscience. Sealing cortical cell fate. Science 2004, 303:48-49.
97. Levy S.E., Mandell D.S., Schultz R.T. Autism. Lancet 2009, 374:1627-1638.
98. Li Y., Liu B., Sailhamer E.A., Yuan Z., Shults C., Velmahos G.C., deMoya M., Shuja F., Butt M.U., Alam H.B. Cell protective mechanism of valproic acid in lethal hemorrhagic shock. Surgery 2008, 144:217-224.
99. Liesi P. Ethanol-exposed central neurons fail to migrate and undergo apoptosis. J. Neurosci. Res. 1997, 48:439-448.
100. Liu J., Lewohl J.M., Dodd P.R., Randall P.K., Harris R.A., Mayfield R.D. Gene expression profiling of individual cases reveals consistent transcriptional changes in alcoholic human brain. J. Neurochem. 2004, 90:1050-1058.
101. Makkonen I., Riikonen R., Kokki H., Airaksinen M.M., Kuikka J.T. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev. Med. Child Neurol. 2008, 50:593-597.
102. Markram K., Rinaldi T., La Mendola D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
103. Marques-Dias M.J., Gonzalez C.H., Rosemberg S. Möbius sequence in children exposed in utero to misoprostol: neuropathological study of three cases. Birth Defects Res., Part A 2003, 67:1002-1007.
104. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 2008, 82:477-488.
105. Mbarek O., Marouillat S., Martineau J., Barthelemy C., Muh J.P., Andres C. Association study of the NF1 gene and autistic disorder. Am. J. Med. Genet. 1999, 88:729-732.
106. McBride K.L., Varga E.A., Pastore M.T., Prior T.W., Manickam K., Atkin J.F., Herman G.E. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 2010, 3:137-141.
107. Menegola E., Di Renzo F., Broccia M.L., Giavini E. Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res., Part C 2006, 78:345-353.
108. Michaelis M., Michaelis U.R., Fleming I., Suhan T., Cinatl J., Blaheta R.A., Hoffmann K., Kotchetkov R., Busse R., Nau H., et al. Valproic acid inhibits angiogenesis in vitro and in vivo. Mol. Pharmacol. 2004, 65:520-527.
109. Miglio G., Rattazzi L., Rosa A.C., Fantozzi R. PPARgamma stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells. Neurosci. Lett. 2009, 454:134-138.
110. Miles J.H., Hadden L.L., Takahashi T.N., Hillman R.E. Head circumference is an independent clinical finding associated with autism. Am. J. Med. Genet. 2000, 95:339-350.
111. Miles J.H., Hillman R.E. Value of a clinical morphology examination in autism. Am. J. Med. Genet. 2000, 91:245-253.
112. Miles J.H., Takahashi T.N., Hong J., Munden N., Flournoy N., Braddock S.R., Martin R.A., Bocian M.E., Spence M.A., Hillman R.E., et al. Development and validation of a measure of dysmorphology: useful for autism subgroup classification. Am. J. Med. Genet. 2008, 146A:1101-1116.
113. Miller G. Neuroscience. New neurons strive to fit in. Science 2006, 311:938-940.
114. Miller M.T., Strömland K., Gillberg C., Johansson M., Nilsson E.W. The puzzle of autism: an ophthalmologic contribution. Trans. Am. Ophthalmol. Soc. 1998, 96:369-385.
115. Miller M.W., Jacobs J.S., Yokoyama R. Neg, a nerve growth factor-stimulated gene expressed by fetal neocortical neurons that is downregulated by ethanol. J. Comp. Neurol. 2003, 460:212-222.
116. Miller M.T., Strömland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism with ophthalmologic malformations: the plot thickens. Trans. Am. Ophthalmol. Soc. 2004, 102:107-120.
117. Miller M.T., Strömland K., Ventura L., Johansson M., Bandim J.M., Gillberg C. Autism associated with conditions characterized by developmental errors in early embryogenesis: a mini review. Int. J. Dev. Neurosci. 2005, 23:201-219.
118. Miyazaki K., Narita N., Narita M. Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int. J. Dev. Neurosci. 2005, 23:287-297.
119. Moessner R., Marshall C.R., Sutcliffe J.S., Skaug J., Pinto D., Vincent J., Zwaigenbaum L., Fernandez B., Roberts W., Szatmari P., Scherer S.W. Contribution of SHANK3 mutations to autism spectrum disorder. Am. J. Hum. Genet. 2007, 81:1289-1297.
120. Mooney S.M., Siegenthaler J.A., Miller M.W. Ethanol induces heterotopias in organotypic cultures of rat cerebral cortex. Cereb. Cortex 2004, 14:1071-1080.
121. Mooney S.M., Varlinskaya E.I. Acute prenatal exposure to ethanol and social behavior: effect of age, sex, and timing of exposure. Behav. Brain Res. 2011, 216:358-364.
122. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., Dean J.C. A clinical study of 57 children with fetal anticonvulsant syndromes. J. Med. Genet. 2000, 37:489-497.
123. Nakamura K., Sekine Y., Ouchi Y., Tsujii M., Yoshikawa E., Futatsubashi M., Tsuchiya K.J., Sugihara G., Iwata Y., Suzuki K., et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatr. 2010, 67:59-68.
124. Nanson J.L. Autism in fetal alcohol syndrome: a report of six cases. Alcohol: Clin. Exp. Res. 1992, 16:558-565.
125. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat; putative animal models for autism. Pediatr. Res. 2002, 52:576-579.
126. Neubert R., Hinz N., Thiel R., Neubert D. Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide. Life Sci. 1996, 58:295-316.
127. Nicholas B., Rudrasingham V., Nash S., Kirov G., Owen M.J., Wimpory D.C. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Mol. Psychiatr. 2007, 12:581-592.
128. Ornoy A. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?. Reprod. Toxicol. 2009, 28:1-10.
129. Ozgen H., Hellemann G.S., Stellato R.K., Lahuis B., van Daalen E., Staal W.G., Rozendal M., Hennekam R.C., Beemer F.A., van Engeland H. Morphological features in children with autism spectrum disorders: a matched case-control study. J. Autism Dev. Disord. 2011, 41:23-31.
130. Park P.H., Lim R.W., Shukla S.D. Involvement of histone acetyltransferase HAT in ethanol-induced acetylation of histone H3 in hepatocytes: potential mechanism for gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G1124-1136.
131. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 2001, 276:36734-36741.
132. Pickett J., London E. The neuropathology of autism: a review. J. Neuropathol. Exp. Neurol. 2005, 64:925-935.
133. Pignataro L., Varodayan F.P., Tannenholz L.E., Harrison N.L. The regulation of neuronal gene expression by alcohol. Pharmacol. Ther. 2009, 124:324-335.
134. Ploeger A., Raijmakers M.E., van der Maas H.L., Galis F. The association between autism and errors in early embryogenesis: what is the causal mechanism?. Biol Psychiatr. 2010, 67:602-607.
135. Pottie K. Is misoprostol teratogenic? Misoprostol use during early pregnancy and its association with Mobius' syndrome. Can. Fam. Physician 1999, 45:315-316.
136. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., Dean J.C. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev. Med. Child Neurol. 2005, 47:551-555.
137. Redcay E., Courchesne E. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol. Psychiatr. 2005, 58:1-9.
138. Rice D., Barone S.J. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 2000, 108:511-533.
139. Rinaldi T., Kulangara K., Antoniello K., Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13501-13506.
140. Rinaldi T., Perrodin C., Markram H. Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front. Neural Circuits 2008, 2:4.
141. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb. Cortex 2008, 18:763-770.
142. Ritvo E.R., Freeman B.J., Scheibel A.B., Duong T., Robinson H., Guthrie D., Ritvo A. Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report. Am. J. Psychiatr. 1986, 143:862-866.
143. Rodier P.M., Bryson S.E., Welch J.P. Minor malformations and physical measurements in autism: data from Nova Scotia. Teratology 1997, 55:319-325.
144. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod. Toxicol. 1997, 11:417-422.
145. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 1996, 370:247-261.
146. Rosser T.L., Packer R.J. Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr. Neurol. Neurosci. Rep. 2003, 3:129-136.
147. Roullet F.I., Wollaston L., Decatanzaro D., Foster J.A. Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid. Neuroscience 2010, 170:514-522.
148. Rout U.K., Clausen P. Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders. Neurosci. Res. 2009, 64:162-169.
149. Rowland T.L., McHugh S.M., Deighton J., Ewan P.W., Dearman R.J., Kimber I. Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B. Int. Immunopharmacol. 2001, 1:49-61.
150. Sari Y., Zhou F.C. Prenatal alcohol exposure causes long-term serotonin neuron deficit in mice. Alcohol: Clin. Exp. Res. 2004, 28:941-948.
151. Sathyan P., Golden H.B., Miranda R.C. Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J. Neurosci. 2007, 27:8546-8557.
152. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J. Pediatr. 1961, 58:315-320.
153. Schneider T., Labuz D., Przewłocki R. Nociceptive changes in rats after prenatal exposure to valproic acid. Pol. J. Pharmacol. 2001, 53:531-534.
154. Schneider T., Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
155. Schneider T., Roman A., Basta-Kaim A., Kubera M., Budziszewska B., Schneider K., Przewłocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008, 33:728-740.
156. Schneider T., Ziòłkowska B., Gieryk A., Tyminska A., Przewłocki R. Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology 2007, 193:547-555.
157. Schumacher H., Blake D.A., Gurian J.M., Gillette J.R. A comparison of the teratogenic activity of thalidomide in rabbits and rats. J. Pharmacol. Exp. Ther. 1968, 160:189-200.
158. Schumann C.M., Amaral D.G. Stereological analysis of amygdala neuron number in autism. J. Neurosci. 2006, 26:7674-7679.
159. Schumann C.M., Barnes C.C., Lord C., Courchesne E. Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol. Psychiatr. 2009, 66:942-949.
160. Scoles D.R., Huynh D.P., Morcos P.A., Coulsell E.R., Robinson N.G., Tamanoi F., Pulst S.M. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin. Nat. Genet. 1998, 18:354-359.
161. Shukla S.D., Velazquez J., French S.W., Lu S.C., Ticku M.K., Zakhari S. Emerging role of epigenetics in the actions of alcohol. Alcohol: Clin. Exp. Res. 2008, 32:1525-1534.
162. Smithells R.W., Newman C.G. Recognition of thalidomide defects. J. Med. Genet. 1992, 29:716-723.
163. Snow W.M., Hartle K., Ivanco T.L. Altered morphology of motor cortex neurons in the VPA rat model of autism. Dev. Psychobiol. 2008, 50:633-639.
164. Stanton M.E., Peloso E., Brown K.L., Rodier P. Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. Behav. Brain Res. 2007, 176:133-140.
165. Stodgell C.J., Ingram J.L., O'Bara M., Tisdale B.K., Nau H., Rodier P.M. Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action. Neurotoxicol. Teratol. 2006, 28:617-624.
166. Strömland K., Nordin V., Miller M., Akerström B., Gillberg C. Autism in thalidomide embryopathy: a population study. Dev. Med. Child Neurol. 1994, 36:351-356.
167. Strömland K., Sjögreen L., Miller M., Gillberg C., Wentz E., Johansson M., Nylén O., Danielsson A., Jacobsson C., Andersson J., et al. Mobius sequence-a Swedish multidiscipline study. Eur. J. Paediatr. Neurol. 2002, 6:35-45.
168. Sugimoto Y., Narumiya S. Prostaglandin E receptors. J. Biol. Chem. 2007, 282:11613-11617.
169. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., Vincent J.B., Skaug J.L., Thompson A.P., Senman L., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39:319-328.
170. Tabuchi K., Blundell J., Etherton M.R., Hammer R.E., Liu X., Powell C.M., Sudhof T.C. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
171. Tang M., Villaescusa J.C., Luo S.X., Guitarte C., Lei S., Miyamoto Y., Taketo M.M., Arenas E., Huang E.J. Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J. Neurosci. 2010, 30:9280-9291.
172. Thiel R., Kastner U., Neubert R. Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative. Life Sci. 2000, 66:133-141.
173. Tripi G., Roux S., Canziani T., Bonnet Brilhault F., Barthélémy C., Canziani F. Minor physical anomalies in children with autism spectrum disorder. Early Hum. Dev. 2008, 84:217-223.
174. Tsuchiya H., Oka T., Nakamura K., Ichikawa A., Saper C.B., Sugimoto Y. Prostaglandin E2 attenuates preoptic expression of GABAA receptors via EP3 receptors. J. Biol. Chem. 2008, 283:11064-11071.
175. Tsujino N., Nakatani Y., Seki Y., Nakasato A., Nakamura M., Sugawara M., Arita H. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neurosci. Res. 2007, 57:289-295.
176. Uchida K., Kumihashi K., Kurosawa S., Kobayashi T., Itoi K., Machida T. Stimulatory effects of prostaglandin E2 on neurogenesis in the dentate gyrus of the adult rat. Zoolog. Sci. 2002, 19:1211-1216.
177. Vangipuram S.D., Grever W.E., Parker G.C., Lyman W.D. Ethanol increases fetal human neurosphere size and alters adhesion molecule gene expression. Alcohol: Clin. Exp. Res. 2008, 32:339-347.
178. Vorhees C.V., Weisenburger W.P., Minck D.R. Neurobehavioral teratogenic effects of thalidomide in rats. Neurotoxicol. Teratol. 2001, 23:255-264.
179. Vourc'h P., Martin I., Bonnet-Brilhault F., Marouillat S., Barthelemy C., Muh J.P., Andres C. Mutation screening and association study of the UBE2H gene on chromosome 7q32 in autistic disorder. Psychiatr. Genet. 2003, 13:221-225.
180. Wang W.M., Zhang H.D., Jin Y.M., Zhu B.B., Chen N. PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. Acta Pharmacol. Sin. 2009, 30:107-112.
181. Wang Z., Xu L., Zhu X., Cui W., Sun Y., Nishijo H., Peng Y., Li R. Demethylation of Specific Wnt/beta-Catenin Pathway Genes and its Upregulation in Rat Brain Induced by Prenatal Valproate Exposure. Anat. Rec. 2010, 293:1947-1953.
182. Wegiel J., Kuchna I., Nowicki K., Imaki H., Wegiel J., Marchi E., Ma S.Y., Chauhan A., Chauhan V., Bobrowicz T.W., et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010, 119:755-770.
183. Wegner C., Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992, 42:17-24.
184. Wentzel P., Eriksson U.J. Altered gene expression in neural crest cells exposed to ethanol in vitro. Brain Res. 2009, 1305(Suppl):S50-60.
185. Wilcox J., Tsuang M.T., Ledger E., Algeo J., Schnurr T. Brain perfusion in autism varies with age. Neuropsychobiology 2002, 46:13-16.
186. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child Neurol. 2001, 43:202-206.
187. Williams P.G., Hersh J.H. A male with fetal valproate syndrome and autism. Dev. Med. Child Neurol. 1997, 39:632-634.
188. Yang H., Zhang J., Breyer R.M., Chen C. Altered hippocampal long-term synaptic plasticity in mice deficient in the PGE2 EP2 receptor. J. Neurochem. 2009, 108:295-304.
189. Yeargin-Allsopp M., Rice C., Karapurkar T., Doernberg N., Boyle C., Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003, 289:49-55.
190. Yochum C.L., Dowling P., Reuhl K.R., Wagner G.C., Ming X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res. 2008, 1203:126-132.
191. Yu I.T., Park J.Y., Kim S.H., Lee J.S., Kim Y.S., Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009, 56:473-480.
192. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 2001, 276:31674-31683.
193. Zhou F.C., Sari Y., Li T.K., Goodlett C., Azmitia E.C. Deviations in brain early serotonergic development as a result of fetal alcohol exposure. Neurotox. Res. 2002, 4:337-342.
194. Zhou F.C., Sari Y., Powrozek T.A. Fetal alcohol exposure reduces serotonin innervation and compromises development of the forebrain along the serotonergic pathway. Alcohol: Clin. Exp. Res. 2005, 29:141-149.
195. Zhou R., Yuan P., Wang Y., Hunsberger J.G., Elkahloun A., Wei Y., Damschroder-Williams P., Du J., Chen G., Manji H.K. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 2009, 34:1395-1405.